SCHEMBL16736683

SCHEMBL16736683

CCCc1cc(Br)c(C)cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HMGCR P04035 2/20 0.48
▸ HTT P42858 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ ALOX5 P09917 2/20 0.38
▸ PTPN1 P18031 1/20 0.37
▸ PTPN11 Q06124 1/20 0.37
▸ MAPT P10636 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ XBP1 P17861 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ TYR P14679 2/20 0.36
▸ HPGD P15428 3/20 0.36
▸ TSHR P16473 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ HSD17B10 Q99714 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ ALOX15 P16050 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16736839 0.89 TYR (0.50) HMGCRHTTALDH1A1ALOX5MAPT
SCHEMBL16736925 0.83 MCL1 (0.47) HTTALDH1A1PTPN1MAPTHPGD
SCHEMBL16736703 0.83 HMGCR (0.52) HMGCRHTTALDH1A1ALOX5PTPN1
SCHEMBL23387409 0.81 HMGCR (0.53) HMGCRHTTALDH1A1ALOX5PTPN1
SCHEMBL13842565 0.81 HMGCR (0.53) HMGCRHTTALDH1A1ALOX5PTPN1
SCHEMBL16736929 0.80 HMGCR (0.48) HMGCRHTTALDH1A1ALOX5PTPN1
SCHEMBL16736747 0.79 HMGCR (0.44) HMGCRHTTALDH1A1ALOX5PTPN1
SCHEMBL21757382 0.79 SHBG (0.44) HTTALDH1A1PTPN1MAPTLMNA
SCHEMBL1760537 0.78 HMGCR (0.64) HMGCRHTTALDH1A1ALOX5PTPN1
SCHEMBL10679856 0.78 HMGCR (0.50) HMGCRHTTALDH1A1ALOX5PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2017-06-22 — — US disclosed
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2017-06-22 — — US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 — — US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 — — US disclosed
US-9630896-B2 2,5-dialkyl-4-H/halo/ether-phenol compounds TANSNA THERAPEUTICS, INC. (US) 2017-04-25 — — US disclosed
WO-2016190871-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. (US) 2016-12-01 — — WO disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 — — US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 — — US disclosed
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS TANSNA THERAPEUTICS, INC. 2015-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170174600-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS COMT, DDT, TYR HMGCR 2432/4885HTT 10/4885ALDH1A1 852/4885
US-20150148430-A1 2,5-DIALKYL-4-H/HALO/ETHER-PHENOL COMPOUNDS COMT, DDT, TYR HMGCR 2432/4885HTT 10/4885ALDH1A1 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback